Information:
Error:
ID
17590
Description
NCT00428090 / GSK-AVA105640 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
Keywords
Versions (2)
- 9/18/16 9/18/16 -
- 9/25/16 9/25/16 -
Uploaded on
September 25, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
REFLECT-1 Concomitant Medication NCT00428090
REFLECT-1 Non-Serious Adverse Events NCT00428090
- StudyEvent: ODM
Similar models
REFLECT-1 Non-Serious Adverse Events NCT00428090
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Patient Study ID
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Concomitant Medications
Item
Where any concomitant medications taken by the subject during the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name (Trade Name preferred) (e.g. Aspirin) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C0013227 (UMLS CUI [1])
Total Daily Dose
Item
Total Daily Dose (e.g. 400) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C2348070 (UMLS CUI [1])
Units
Item
Units (e.g. mg) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C1519795 (UMLS CUI [1])
Route
Item
Route (e.g. PO) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C0013153 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication (e.g. Headache) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Start date
Item
Start Date (Day Month Year) (e.g. 31 MAY 02) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
date
C0013227 (UMLS CUI [1])
Stop Date
Item
Stop Date (Day Month Year) (e.g. 31 MAY 02) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
date
C0806020 (UMLS CUI [1])
Ongoing Medication
Item
Ongoing Medication (Yes - No) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
boolean
C2826666 (UMLS CUI [1])